Skip to Main Content

Author Details

Joseph L Chin
University of Western Ontario
1982
317
51
PMIDPaper TitleJournal TitlePublished Year
37838556Magnetic Resonance Imaging-Targeted Versus Systematic Prostate Biopsies: 2-year Follow-up of a Prospective Randomized Trial (PRECISE).Eur Urol Oncol2024
37439809Neoadjuvant Cabazitaxel plus Abiraterone/Leuprolide Acetate in Patients with High-Risk Prostate Cancer: ACDC-RP Phase II Trial.Clin Cancer Res2023
37494316Genetic testing practices among specialist physicians who treat prostate cancer A Canadian, cross-sectional survey.Can Urol Assoc J2023
37126232Multimodal Biomarkers That Predict the Presence of Gleason Pattern 4: Potential Impact for Active Surveillance.J Urol2023
37081426The use of Lutetium-177 PSMA radioligand therapy with high dose rate brachytherapy for locally recurrent prostate cancer after previous definitive radiation therapy: a randomized, single-institution, phase I/II study (ROADSTER).BMC Cancer2023
34812728Metastatic progression following multimodal therapy for unfavorable-risk prostate cancer.Can Urol Assoc J2022
35668135The metabolic enzyme hexokinase 2 localizes to the nucleus in AML and normal haematopoietic stem and progenitor cells to maintain stemness.Nat Cell Biol2022
35358408QUEST at 25: An enduring innovation in Canadian urology.Can Urol Assoc J2022
36656699Artificial intelligence for prostate cancer histopathology diagnostics.Can Urol Assoc J2022
36095953Prostate cancer classification using radiomics and machine learning on mp-MRI validated using co-registered histology.Eur J Radiol2022
35076300Effect of <sup>18</sup>F-DCFPyL PET/CT on the Management of Patients with Recurrent Prostate Cancer: Results of a Prospective Multicenter Registry Trial.Radiology2022
34978211Low Serum Testosterone in Men with Newly Diagnosed Androgen-Deprivation Therapy-Naïve Prostate Cancer and Its Relationship to Cardiovascular Risk Factors: A RADICAL-PC Substudy.J Urol2022
35337747Targeting prostate lesions on multiparametric MRI with HDR brachytherapy: Optimal planning margins determined using whole-mount digital histology.Brachytherapy2022
32814843Long-term outcomes of two ablation techniques for treatment of radio-recurrent prostate cancer.Prostate Cancer Prostatic Dis2021
33716036A Randomized Controlled Trial of a Modified Cystoscopy Technique using the Peak-End Rule in order to Improve Pain and Anxiety.Urology2021
33648893A multiobserver study investigating the effectiveness of prostatic multiparametric magnetic resonance imaging to dose escalate corresponding histologic lesions using high-dose-rate brachytherapy.Brachytherapy2021
34589619Prostate specific membrane antigen positron emission tomography for lesion-directed high-dose-rate brachytherapy dose escalation.Phys Imaging Radiat Oncol2021
34584809Characterizing Surgical and Radiotherapy Outcomes in Non-metastatic High-Risk Prostate Cancer: A Systematic Review and Meta-Analysis.Cureus2021
34400038Multiparametric Magnetic Resonance Imaging in the Diagnosis of Clinically Significant Prostate Cancer: an Updated Systematic Review.Clin Oncol (R Coll Radiol)2021
34652551Short-duration dynamic [<sup>18</sup>F]DCFPyL PET and CT perfusion imaging to localize dominant intraprostatic lesions in prostate cancer: validation against digital histopathology and comparison to [<sup>18</sup>F]DCFPyL PET/MR at 120 minutes.EJNMMI Res2021
33253070Editorial Comment.J Urol2021
33394284Kinetic analysis of dominant intraprostatic lesion of prostate cancer using quantitative dynamic [<sup>18</sup>F]DCFPyL-PET: comparison to [<sup>18</sup>F]fluorocholine-PET.EJNMMI Res2021
33234494Cognition and depression effects of androgen receptor axis-targeted drugs in men with prostate cancer: A systematic review.J Geriatr Oncol2021
33410740Longitudinal experience with Studer neobladders: Outcomes and complications.Can Urol Assoc J2021
33007180Does adding local salvage ablation therapy provide survival advantage for patients with locally recurrent prostate cancer following radiotherapy? Whole gland salvage ablation post-radiation failure in prostate cancer.Can Urol Assoc J2021
32935575Relief of Lower Urinary Tract Symptoms After MRI-Guided Transurethral Ultrasound Ablation for Localized Prostate Cancer: Subgroup Analyses in Patients with Concurrent Cancer and Benign Prostatic Hyperplasia.J Endourol2021
32453694Continuing towards optimization of bladder cancer care in Canada: Summary of the third Bladder Cancer Canada-Canadian Urological Association-Canadian Urologic Oncology Group (BCC-CUA-CUOG) bladder cancer quality of care consensus meeting.Can Urol Assoc J2020
33704177Primary Mediastinal Germ Cell Tumors-The University of Western Ontario Experience.Curr Oncol2020
31899651Cardiovascular Risk in Men with Prostate Cancer: Insights from the RADICAL PC Study.J Urol2020
31926754The Singularity is Near(ish): Emerging Applications of Artificial Intelligence in Prostate Cancer Management.Eur Urol2020
32717361Is prostate brachytherapy a dying art? Trends and variation in the definitive management of prostate cancer in Ontario, Canada.Radiother Oncol2020
32605858Re: Benefits and Risks of Primary Treatments for High-risk Localized and Locally Advanced Prostate Cancer: An International Multidisciplinary Systematic Review.Eur Urol2020
32715024Automatic cancer detection on digital histopathology images of mid-gland radical prostatectomy specimens.J Med Imaging (Bellingham)2020
32827589Histologic validation of auto-contoured dominant intraprostatic lesions on [<sup>18</sup>F] DCFPyL PSMA-PET imaging.Radiother Oncol2020
32680677Small Renal Mass Surveillance: Histology-specific Growth Rates in a Biopsy-characterized Cohort.Eur Urol2020
32218666Complex surgery and perioperative systemic therapy for genitourinary cancer of the retroperitoneum.Curr Oncol2020
32555410Histologic tissue components provide major cues for machine learning-based prostate cancer detection and grading on prostatectomy specimens.Sci Rep2020
32391232Cryosurgery Versus Primary Androgen Deprivation Therapy for Locally Recurrent Prostate Cancer After Primary Radiotherapy: A Propensity-Matched Survival Analysis.Cureus2020
32308085Salvage open radical prostatectomy for recurrent prostate cancer following MRI-guided transurethral ultrasound ablation (TULSA) of the prostate: feasibility and efficacy.Scand J Urol2020
32569569The history of renal transplantation in Canada: A urologic perspective.Can Urol Assoc J2020
32569568Real-world evidence in patient-reported outcomes (PROs) of metastatic castrate-resistant prostate cancer (mCRPC) patients treated with abiraterone acetate + prednisone (AA+P) across Canada: Final results of COSMiC.Can Urol Assoc J2020
30430700Characterization of clinical human prostate cancer lesions using 3.0-T sodium MRI registered to Gleason-graded whole-mount histopathology.J Magn Reson Imaging2019
32280821Dosimetric Evaluation of PSMA PET-Delineated Dominant Intraprostatic Lesion Simultaneous Infield Boosts.Adv Radiat Oncol2019
30017404Active Surveillance Magnetic Resonance Imaging Study (ASIST): Results of a Randomized Multicenter Prospective Trial.Eur Urol2019
31524572Editorial Comment.J Urol2019
31433512A three-gene DNA methylation biomarker accurately classifies early stage prostate cancer.Prostate2019
28583310Robotic-assisted Radical Prostatectomy for High-risk Cancer: Time for "Sexta-fecta".Eur Urol2018
30070154Editorial Comment on: Focal Treatment for Unilateral Prostate Cancer Using High-Intensity Focal Ultrasound: A Comprehensive Study of Pooled Data by Albisinni et al.J Endourol2018
29875044Chronic renal pain: An approach to investigation and management.Can Urol Assoc J2018
29381462Next-generation prostate cancer risk calculator for primary care physicians.Can Urol Assoc J2018
  • 1 - 50 of 317

Recommended Authors

university of california san diego School of Medicine
Career Start Year 2011
Number of shared co-authors 1
Columbia University Medical Center
Career Start Year 2010
Number of shared co-authors 0
University Hospital Center Sestre Milosrdnice
Career Start Year 2008
Number of shared co-authors 9
University of Alberta
Career Start Year 2007
Number of shared co-authors 4
University of Washington Medical Center
Career Start Year 2005
Number of shared co-authors 8
Peter MacCallum Cancer Centre, University of Melbourne
Career Start Year 2005
Number of shared co-authors 12
University of California San Diego
Career Start Year 2005
Number of shared co-authors 1
Asan Medical Center, University of Ulsan College of Medicine
Career Start Year 2002
Number of shared co-authors 1
University Hospital Southampton NHS Foundation Trust
Career Start Year 2002
Number of shared co-authors 3
University of Michigan ann arbor
Career Start Year 1997
Number of shared co-authors 18
Royal Melbourne Hospital, The University of Melbourne
Career Start Year 1997
Number of shared co-authors 11
The Royal Marsden NHS Foundation Trust
Career Start Year 1996
Number of shared co-authors 2
University of Illinois at Chicago
Career Start Year 1996
Number of shared co-authors 0
University of Texas Southwestern Medical Center at Dallas
Career Start Year 1994
Number of shared co-authors 6
New York-Presbyterian Hospital
Career Start Year 1994
Number of shared co-authors 11
Duke University School of Medicine
Career Start Year 1993
Number of shared co-authors 9
Asan Medical Center, University of Ulsan College of Medicine
Career Start Year 1993
Number of shared co-authors 4
Washington State University Elson S. Floyd College of Medicine
Career Start Year 1992
Number of shared co-authors 9
Hospitalier Universitaire de Saint-Etienne
Career Start Year 1989
Number of shared co-authors 10
University of California Davis
Career Start Year 1988
Number of shared co-authors 18
Monash University
Career Start Year 1988
Number of shared co-authors 14
Liverpool University Hospitals
Career Start Year 1988
Number of shared co-authors 3
University of Melbourne
Career Start Year 1988
Number of shared co-authors 8
University of Oxford
Career Start Year 1987
Number of shared co-authors 12
Amsterdam University Medical Centers, University of Amsterdam
Career Start Year 1987
Number of shared co-authors 10
Eberhard Karls University of Tubingen
Career Start Year 1984
Number of shared co-authors 10
Johns Hopkins University School of Medicine
Career Start Year 1984
Number of shared co-authors 15
University of Oxford, John Radcliffe Hospital
Career Start Year 1981
Number of shared co-authors 19
Royal Melbourne Hospital
Career Start Year 1974
Number of shared co-authors 11
Martini-Klinik Prostate Cancer Center, University Hospital-Hamburg-Eppendorf
Career Start Year 1971
Number of shared co-authors 10

Collaborators

Schulich School of Medicine and Dentistry, University of Western Ontario
Co-authored papers 44
Western University and London Regional Cancer Program
Co-authored papers 35
University of Montreal Health Center
Co-authored papers 26
CHU de Quebec-Universite Laval
Co-authored papers 26
CHU de Quebec-Universite Laval
Co-authored papers 24
University of Toronto
Co-authored papers 16
McGill University Health Centre, McGill University
Co-authored papers 16
Schulich School of Medicine and Dentistry, University of Western Ontario
Co-authored papers 13
Queen's University
Co-authored papers 13
Princess Margaret Hospital, University of Toronto
Co-authored papers 12
University Health Network
Co-authored papers 10
University of British Columbia
Co-authored papers 8
Princess Margaret Cancer Centre, University Health Network and University of Toronto
Co-authored papers 8
University of Western Ontario
Co-authored papers 7
Princess Margaret Cancer Center, University Health Network.
Co-authored papers 7
University of Toronto, University Health Network
Co-authored papers 6
McGill University Health Centre, McGill University
Co-authored papers 5
CHRISTUS Santa Rosa Hospital-Medical Center
Co-authored papers 5
University of Western Ontario
Co-authored papers 5
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Co-authored papers 4
Cancer Centre of Southeastern Ontario
Co-authored papers 4
Western University, Lawson Health Research Institute
Co-authored papers 4
Co-authored papers 4
The University of Western Ontario
Co-authored papers 3
University of Toronto
Co-authored papers 3
University Health Network, Princess Margaret Cancer Center, University of Toronto
Co-authored papers 3
University of Colorado School of Medicine
Co-authored papers 3
University of Toronto
Co-authored papers 3
University of British Columbia
Co-authored papers 3
Western University and London Regional Cancer Program
Co-authored papers 3